We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$165M
AUM Growth
-$4.08M
Cap. Flow
+$2.01M
Cap. Flow %
1.22%
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$1.05M
2
VMC icon
Vulcan Materials
VMC
+$1.01M
3
CSGP icon
CoStar Group
CSGP
+$998K
4
LLY icon
Eli Lilly
LLY
+$967K
5
IR icon
Ingersoll Rand
IR
+$913K

Sector Composition

Rank Sector Weight
1 Healthcare 18.63%
2 Financials 17.26%
3 Technology 14.89%
4 Energy 9.42%
5 Consumer Discretionary 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAIN icon
176
Main Street Capital
MAIN
$5B
$453K 0.28%
11,149
+5,734
+106% +$234K
RWAY icon
177
Runway Growth Finance
RWAY
$231M
$450K 0.27%
35,080
+15,404
+78% +$198K
CION icon
178
CION Investment
CION
$298M
$442K 0.27%
41,848
+21,982
+111% +$238K
INSM icon
179
Insmed
INSM
$22.7B
$398K 0.24%
15,777
-2,037
-11% -$46.6K
RYTM icon
180
Rhythm Pharmaceuticals
RYTM
$7.28B
$394K 0.24%
17,193
-2,221
-11% -$49.7K
CHWY icon
181
Chewy
CHWY
$8.93B
$386K 0.23%
+21,146
New +$605K
IQI icon
182
Invesco Quality Municipal Securities
IQI
$526M
$379K 0.23%
+45,117
New +$416K
OFS icon
183
OFS Capital
OFS
$46M
$377K 0.23%
33,544
+14,844
+79% +$157K
AMGN icon
184
Amgen
AMGN
$203B
$371K 0.23%
1,379
-167
-11% -$41.7K
ROIV icon
185
Roivant Sciences
ROIV
$25B
$366K 0.22%
31,338
-4,051
-11% -$45.8K
MRCC
186
DELISTED
Monroe Capital Corp
MRCC
$365K 0.22%
48,943
+25,463
+108% +$201K
NBIX icon
187
Neurocrine Biosciences
NBIX
$17.7B
$363K 0.22%
3,227
-420
-12% -$44.2K
EXEL icon
188
Exelixis
EXEL
$14B
$354K 0.22%
16,201
-2,096
-11% -$43.8K
BCIC
189
BCP Investment Corp
BCIC
$88.1M
$354K 0.21%
18,374
+9,546
+108% +$190K
HALO icon
190
Halozyme
HALO
$9.66B
$353K 0.21%
9,231
-1,191
-11% -$48.8K
OXSQ icon
191
Oxford Square Capital
OXSQ
$148M
$351K 0.21%
116,717
+54,949
+89% +$166K
BXSL icon
192
Blackstone Secured Lending
BXSL
$5.35B
$348K 0.21%
12,718
+6,713
+112% +$186K
MIRM icon
193
Mirum Pharmaceuticals
MIRM
$6.96B
$339K 0.21%
10,739
-1,390
-11% -$38.1K
IONS icon
194
Ionis Pharmaceuticals
IONS
$9.25B
$338K 0.21%
7,457
-961
-11% -$39.6K
EXR icon
195
Extra Space Storage
EXR
$31.3B
$337K 0.2%
2,773
+1,319
+91% +$177K
KNSA icon
196
Kiniksa Pharmaceuticals
KNSA
$4.89B
$321K 0.19%
18,461
-2,390
-11% -$40.3K
ASND icon
197
Ascendis Pharma A/S
ASND
$16.6B
$315K 0.19%
3,368
-434
-11% -$40.6K
NRP icon
198
Natural Resource Partners
NRP
$1.3B
$312K 0.19%
3,953
-272
-6% -$17.7K
UTHR icon
199
United Therapeutics
UTHR
$26.3B
$303K 0.18%
1,342
-177
-12% -$40.8K
BNTX icon
200
BioNTech
BNTX
$23B
$298K 0.18%
2,740
-357
-12% -$39.5K

Similar funds

Virtus ETF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Virtus ETF Advisers held 488 positions worth $165M, down 2.4% from $169M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers's Q3 2023 filing shows 53 new, 73 increased, 307 reduced and 54 closed positions. Its largest new stake was Alphabet (Google) Class A: 6,222 shares worth $814K. The largest sale was Netflix, an estimated $1.05M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 28% a quarter earlier, followed by Financials and Technology.

  • Virtus ETF Advisers's largest Q3 2023 buy was Alphabet (Google) Class A: 6,222 shares worth $814K.
  • Virtus ETF Advisers added most to Coterra Energy in Q3 2023, an estimated $732K increase.
  • Virtus ETF Advisers's biggest Q3 2023 reduction was Incyte, cutting an estimated $701K.
  • Virtus ETF Advisers fully exited Netflix in Q3 2023, selling an estimated $1.05M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $165M portfolio in Q3 2023.
  • Virtus ETF Advisers opened 53 new positions and closed 54 in Q3 2023.
  • Virtus ETF Advisers's portfolio value fell 2.4% quarter-over-quarter to $165M.

Based on Virtus ETF Advisers's 13F filing for Q3 2023, filed 7 Nov 2023.